Introduction {#sec1-1}
============

Thyroid cancer (TC) is the most common malignancy of the endocrine system in human, which accounts for nearly 3.8% of newly diagnosed cancers annually (Visciano et al., 2015; SEER, 2016). According to the last reports, the incidence of TC is the third fastest rising cancer diagnosis in the USA, which its incidence is rapidly increasing from 7.6 to 14.9 per 100,000 in a decade (between 2000 and 2012) (De Lellis, 2004; Morris et al., 2013).

Thyroid malignancies are categorized into several subtypes including follicular (FTC), papillary (PTC), medullary (MTC), undifferentiated, Hurthle cell and a subgroup of rare morphologies such as mucoepidermoid, oncocytic carcinomas and squamous (DeLellis, 2004; Schneider et al., 2013). In addition, TC could be categorized as either sporadic or familial, which only 5-7% of TC cases are familial (Nagy and Ringel, 2015; Haugen et al. 2016). According to the studies, a TC risk factors is very complex, simply is anything that causes to increase the susceptibility of TC. However, a combination of genetic and environmental factors (predominantly including: age, gender, ethnicity, family history, radiation exposure and iodine intake) likely contributes to the development of TC. The underlying genetics cause of TC varies based on its histology. The genetic cause of MTC is well identified. Hereditary MTC is caused by mutations in the RET proto-oncogene that cause multiple endocrine neoplasia 2A (MEN2A) syndrome characterized by MTC, parathyroid hyperplasia and pheochromocytoma, and multiple endocrine neoplasia 2A (MEN2B) syndrome characterized by MTC, pheochromocytoma, mucosal neuromas, and tall, asthenic habitus. However, the genetic causes of familial non-medullary thyroid carcinoma (FNMTC) are less understood (Morrison et al., 2009; Nagy and Ringel, 2015).

Associations between X-ray cross complementary group 1 protein (XRCC1) gene polymorphisms and multiple cancers have already been reported. Three major polymorphisms of the XRCC1 gene have been identified at codon 194 (rs1799782, C \> T substitution at position 26304, exon 6, Arg to Trp), at codon 280 (rs25489, C \> T substitution at position 43552260, exon 9, Arg to His), and at codon 399 (rs25487, G \> A substitution at position 28152, exon 10, Arg to Gln) (Garcia et al. 2011; Santos et al. 2012; and Halkova et al. 2016). Recently, several studies have demonstrated that the polymorphism of XRCC1 gene was associated with the TC. However, these results were inconsistent. And for the relatively small sample size of the published studies, it is necessary to accumulate data from different studies to provide evidence on the association of XRCC1 gene polymorphisms with risk of TC. Moreover, in recent years more studies with large sample have been published. Therefore, we performed a meta-analysis to further estimate the overall risk of TC caused by the XRCC1 rs1799782 (Arg194Trp), rs25487 (Arg399Gln) and rs25489 (Arg280His) polymorphisms in patients.

Materials and Methods {#sec1-2}
=====================

Literature search strategy {#sec2-1}
--------------------------

The databases include Pubmed, Google Scholar, MEDLINE, ISI Web of Science and SCOPUS database up to January 5th, 2017 to identify all relevant articles on the subject. We have used various combinations of keywords to screen for potentially relevant studies, including "Thyroid cancer"; "DNA repair gene", "XRCC1" or "XRCC1 DNA repair protein"; "Genetic polymorphism" or "single nucleotide polymorphism" or "polymorphism" or "SNP" or "mutation" or "variation", with restricted to English language and only published studies with full-text articles available. All eligible studies were retrieved, then we also manually searched the references of included studies to identify more potentially relevant articles.

Including and Excluding Criteria {#sec2-2}
--------------------------------

Studies included to the meta-analysis had to be consistent with the following criteria: (1) only studied on human; (2) only the case--control studies and cohorts, (3) studies have evaluated the XRCC1 rs1799782 (Arg194Trp), rs25487 (Arg399Gln) and rs25489 (Arg280His) polymorphisms and TC risk, and (4) sufficient published data (specially frequency of the genotypes) for estimating an odds ratio (OR) with 95% confidence interval (CI). Major reasons for exclusion of studies were as follows: (1) not on human, (2) not cancer research (3) only on patients, (4) duplicate of previous papers, and (5) have not sufficient data about frequency of genotypes.

Data extraction {#sec2-3}
---------------

Two authors carefully and independently were extracted the data from all eligible publications using a structured table. The following items were considered: first author's name, year of publication, ethnicity, and country of study population, number of cases and controls, genotype number in cases and controls, and p- value for Hardy-Weinberg equilibrium (HWE). The subject's ethnicities were categorized as Caucasian, Asian, or African. Disagreements were resolved in consultation with the third reviewer.

Statistical Analysis {#sec2-4}
--------------------

An ethical approval was not necessary needed as this is a meta-analysis based on previous studies. The strength of association between XCCR1 gene polymorphism and TC risk was tested by odds ratios (ORs) with 95% confidence intervals (CIs) using Z test. The summarized ORs were performed for rs1799782 (allele model: T vs. C, heterozygote model: TC vs. CC, homozygote model: TT vs. CC, dominant model: TT+TC vs. CC, and recessive model: TT vs. TC+CC), rs25487 (allele model: A vs. G, heterozygote model: AG vs. GG, homozygote model: AA vs. GG, dominant model: AA+AG vs. GG, and recessive model: AA vs. AG+GG), rs25489 (allele model: A vs. G, heterozygote model: AG vs. GG, homozygote model: AA vs. GG, dominant model: AA+AG vs. GG, and recessive model: AA vs. AG+GG) polymorphisms.

The Chi-squared Q-test and I2 statistics were used to identify the heterogeneity among included publications (Zintzaras et al., 2005). The fixed-effects model (the Mantel--Haenszel method) is used when the effects are assumed to be homogenous (P ≥ 0.1 or I2 \<50%). Otherwise, the random effects model (the DerSimonian and Laird method) is used when they are heterogeneous (P \< 0.1 or I2 ≥ 50%). Subgroup analyses by ethnicity was also performed to identify the substantial heterogeneity. Additionally, the effect of each single study on the overall estimate was determined by application of one-way sensitivity analysis. The sensitivity analysis was performed by omitting 1 study at a time. To examine the potential publication bias in the meta analysis, Begg's funnel plot and Egger's test were used; P\<0.05 indicated that the result was statistically significant (Song et al., 1998; Peters et al., 2006). All the statistical analyses were performed by comprehensive meta-analysis (CMA) V2.0 software (Biostat, USA). Two-sided P values \< 0.05 were considered statistically significant.

Results {#sec1-3}
=======

Characteristics of the published studies {#sec2-5}
----------------------------------------

Initially, we have identified 39 publications, among which 18 irrelevant articles were excluded. Thus, 21 publications were eligible. Among these publications, six publications were excluded because they were review articles and other polymorphisms of XRCC1 gene, and also one paper was excluded because of it subject overlapped with other included study. As seen in Tables [1](#T1 T2){ref-type="table"}-[3](#T3){ref-type="table"}, 14 case--control studies were selected in the final meta-analysis, including 8 case--control studies with a total of 1,672 cases and 2,805 controls concerning the XRCC1 rs1799782 polymorphism ([Table 1](#T1){ref-type="table"}), 14 studies with a total of 2,506 cases and 5,180 controls for XRCC1 rs25487 polymorphism ([Table 2](#T2){ref-type="table"}), and 11 studies with a total of 2,197 cases and 4,761 controls for XRCC1 rs25489 polymorphism ([Table 3](#T3){ref-type="table"}). The article performed by Akulevich et al. was separated as 2 studies for they evaluated 2 different Russian and Belarus population. The year of publication ranged between 2008 and 2016. There were 7 studies of Caucasian descendants (Sigurdsson et al., 2009; Akulevich et al., 2009; Ho et al., 2009; Garcia et al., 2011; Santos et al. 2012; and Halkova et al. 2016) and 7 studies of Asian descendants (Zhu et al., 2004; Chiang et al., 2008; Siraj et al. 2008; Esfahani et al. 2011; Ryu et al., 2011; Wang et al., 2015 and Yan et al., 2015). The populations came from different countries, including China, India, Iran, Brazil, Russia, Belarus, Korea, Spain, Portugal, Czech and Kingdom of Saudi Arabia (KSA). Genotype distributions in the controls of 3 publication (predominantly, the publication of Wang et al., 2015) were not in agreement with HWE.

###### 

Characteristics of Studies Included in the Meta Analysis of XRCC1 rs1799782 Polymorphism and TC

  First author           Country (Ethnicity)    Case/Control   Cases   Control   HWE                                            
  ---------------------- ---------------------- -------------- ------- --------- ----- ----- ----- ----- ----- ---- ----- ----- ---------
  Chiang et al. 2008     China (Asian)          283/469        127     119       37    373   193   254   119   36   627   191   0.002
  Ho et al. 2009         USA (Caucasian)        251/503        203     45        3     451   51    433   69    1    935   71    0.306
  Esfahani et al. 2011   Iran (Asian)           157/187        136     18        3     290   24    166   20    1    352   22    0.641
  Ryu et al. 2011        Korea (Asian)          111/100        59      43        9     161   61    37    49    14   123   77    0.728
  Santos et al. 2012     Portugal (Caucasian)   109/217        98      8         2     204   12    196   21    0    413   21    0.453
  Yan et al. 2015        China (Asian)          276/403        124     112       40    360   192   202   173   28   577   229   0.267
  Wang et al. 2015       China (Asian)          276/552        181     52        43    414   138   411   95    46   917   187   \<0.001
  Halkova et al. 2016    Czech (Caucasian)      209/374        178     31        0     387   31    314   59    1    687   61    0.304

###### 

Characteristics of Studies Included in the Meta Analysis of XRCC1 rs25487 Polymorphism and TC

  First author             Country (Ethnicity)    Case/Control   Cases   Controls   HWE                                              
  ------------------------ ---------------------- -------------- ------- ---------- ----- ----- ----- ----- ----- ---- ------- ----- -------
  Zhu et al. 2004          China (Asian)          105/105        49      44         12    208   134   57    45    3    159     51    0.092
  Chiang et al. 2008       China (Asian)          283/469        150     110        23    410   156   277   165   27   719     219   0.711
  Siraj et al. 2008        Saudi Arabia (Asian)   50/299         35      13         2     83    17    142   72    15   356     102   0.164
  Sigurdsson et al. 2009   Russia (Caucasian)     24/892         12      10         2     34    14    460   343   89   1,263   521   0.036
  Akulevich et al. 2009    Russia (Caucasian)     132/398        65      53         14    183   81    158   193   47   509     287   0.302
  Akulevich et al. 2009    Belarus (Caucasian)    123/199        55      50         18    160   86    75    100   22   250     144   0.185
  Ho et al. 2009           USA (Caucasian)        251/503        133     99         19    365   137   220   216   67   656     350   0.229
  Esfahani et al. 2011     Iran (Asian)           155/190        78      60         17    216   94    83    87    20   253     127   0.69
  Ryu et al. 2011          Korea (Asian)          111/100        87      17         7     191   31    72    19    9    163     37    0.002
  Garcia et al. 2011       Spain (Caucasian)      402/479        153     186        47    492   280   196   212   66   604     344   0.476
  Santos et al. 2012       Portugal (Caucasian)   109/217        46      50         13    142   76    87    105   25   279     155   0.428
  Wang et al. 2015         China (Asian)          276/552        138     105        32    381   169   290   206   56   786     318   0.034
  Yan et al. 2015          China (Asian)          276/403        146     108        22    400   152   176   173   54   525     281   0.271
  Halkova et al. 2016      Czech (Caucasian)      209/374        97      81         31    275   143   164   160   50   488     260   0.272

###### 

Characteristics of Studies Included in the Meta Analysis of XRCC1 rs25489 Polymorphism and TC

  First author            Country (Ethnicity)    Case/Control   Cases   Controls   HWE                                             
  ----------------------- ---------------------- -------------- ------- ---------- ----- ----- ----- ----- ----- ---- ------ ----- ---------
  Chiang et al. 2008      China (Asian)          283/469        224     54         5     502   64    349   113   7    811    127   0.528
  Siraj et al. 2008       Saudi Arabia (Asian)   50/299         33      12         5     78    22    129   79    21   337    121   0.088
  Sigurdson et al. 2009   Russia (Caucasian)     25/896         24      1          0     49    1     800   96    0    1696   96    0.902
  Akulevich et al. 2009   Russia (Caucasian)     132/398        117     15         0     249   15    366   32    0    764    32    0.403
  Akulevich et al. 2009   Belarus (Caucasian)    123/195        113     10         0     236   10    176   19    0    371    19    0.474
  Ho et al. 2009          USA (Caucasian)        251/503        229     22         0     480   22    453   50    0    956    50    0.24
  Esfahani et al. 2011    Iran (Asian)           170/193        146     23         1     315   25    173   18    2    364    22    0.065
  Garcia et al. 2011      Spain (Caucasian)      402/479        337     58         3     732   64    426   44    3    896    50    0.123
  Wang et al. 2015        China (Asian)          276/552        153     91         32    397   155   322   174   56   818    286   \<0.001
  Yan et al. 2015         China (Asian)          276/403        218     52         6     488   64    298   97    8    693    113   0.974
  Halkova et al. 2016     Czech (Caucasian)      209/374        188     19         2     395   23    338   36    0    712    36    0.328

Meta-analysis {#sec2-6}
-------------

### XRCC1 rs1799782 Polymorphism {#sec3-1}

[Table 4](#T4){ref-type="table"} listed the main results of the meta-analysis of XRCC1 rs1799782 (Arg194Trp) polymorphism and TC risk ([Figure 1A](#F1){ref-type="fig"}). When all the eligible studies were pooled into the meta-analysis of XRCC1 Arg194Trp polymorphism, significantly increased risk of TC was observed in homozygote (TT vs. CC: OR = 1.815, 95% CI = 1.115-2.953, p= 0.016) and recessive (TT vs. TC+CC: OR = 1.854, 95% CI = 1.433-2.399, p= \<0.001). In the subgroup analysis by ethnicity, significantly increased TC risk was observed in Asians only under recessive model (TT vs. TC+CC: OR = 1.816, 95% CI = 1.398-2.358, p= \<0.001) by using fixed-effect model, but not among Caucasians.

###### 

Meta-Analysis of the Association of XRCC1 rs1799782 Polymorphism with TC

              Genetic model   Type of model   Heterogeneity   Odds ratio                          
  ----------- --------------- --------------- --------------- ------------ ------- -------------- ---------
  Overall                                                                                         
              T vs. C         Random          77.5            \<0.001      1.276   0.980-1.660    0.07
              TC vs. CC       Random          64.0            0.007        1.122   0.856-1.470    0.406
              TT vs. CC       Random          51.9            0.042        1.815   1.115-2.953    0.016
              TT+TC vs. CC    Random          77.9            \<0.001      1.232   0.895-1.696    0.201
              TT vs. TC+CC    Fixed           37.8            0.128        1.854   1.433-2.399    \<0.001
  Ethnicity                                                                                       
  Caucasian                                                                                       
              T vs. C         Fixed           29.1            0.244        1.202   0.919-1.572    0.179
              TC vs. CC       Fixed           19.1            0.29         1.092   0.782-1.527    0.605
              TT vs. CC       Fixed           0.0             0.389        4.031   0.828-19.620   0.084
              TT+TC vs. CC    Fixed           21.3            0.281        1.161   0.872-1.544    0.307
              TT vs. TC+CC    Fixed           0.0             0.397        3.956   0.813-19.246   0.088
  Asian                                                                                           
              T vs. C         Random          84.9            \<0.001      1.323   0.932-1.879    0.117
              TC vs. CC       Random          75.8            0.002        1.141   0.774-1.683    0.504
              TT vs. CC       Random          66.1            0.019        1.681   0.995-2.838    0.052
              TT+TC vs. CC    Random          85.2            \<0.001      1.289   0.823-2.020    0.267
              TT vs. TC+CC    Fixed           52.9            0.075        1.816   1.398-2.358    \<0.001

![Forest Plots Showed Significant Association between XRCC1 Polymorphisms and TC Risk. A: XRCC1 rs1799782 polymorphism (Allele model: T vs. C) and B: XRCC1 rs25487 polymorphism (Homozygote model: AA vs. GG)](APJCP-18-263-g001){#F1}

XRCC1 rs25487 Polymorphism {#sec2-7}
--------------------------

The main results of XRCC1 rs25487 (Arg399Gln) polymorphism meta-analysis are listed in [Table 5](#T5){ref-type="table"}. Overall, there was no evidence of an association between TC risk and the XRCC1 rs25487 polymorphism in the different genetic models when all the eligible studies were pooled into the meta-analysis (A vs. G: OR= 1.131, 95% CI = 0.829-1.543, p= 0.136; AG vs. GG: OR= 0.903, 95% CI = 0.811-1.006, p= 0.063; AA vs. GG: OR= 0.892, 95% CI = 0.690-1.153, p=0.382, [Figure 1B](#F1){ref-type="fig"}; AA+AG vs. GG: OR= 0.880, 95% CI = 0.766-1.012, p= 0.073; and AA vs. AG+GG: OR= 0.940, 95% CI = 0.797-1.109, p= 0.462). For ethnicity, the results showed XRCC1 rs25487 polymorphism was associated with increased risk of TC among Caucasians under allele genetic comparison (A vs. G: OR= 0.882, 95% CI = 0.794-0.979, p= 0.136) and dominant genetic comparison (AA+AG vs. GG: OR=0.838, 95% CI = 0.728-0.965, p= 0.014; [Table 2](#T2){ref-type="table"}), but not among Asians.

###### 

Meta-Analysis of the Association of XRCC1 rs25487 Polymorphism with TC

              Genetic model   Type of model   Heterogeneity   Odds ratio                         
  ----------- --------------- --------------- --------------- ------------ ------- ------------- -------
  Overall                                                                                        
              A vs. G         Random          93.3            \<0.001      1.131   0.829-1.543   0.136
              AG vs. GG       Fixed           14.4            0.296        0.903   0.811-1.006   0.063
              AA vs. GG       Random          48.4            0.022        0.892   0.690-1.153   0.382
              AA+AG vs. GG    Random          42.3            0.048        0.88    0.766-1.012   0.073
              AA vs. AG+GG    Fixed           33.0            0.111        0.94    0.797-1.109   0.462
  Ethnicity                                                                                      
  Caucasian                                                                                      
              A vs. G         Fixed           0.0             0.429        0.882   0.794-0.979   0.018
              AG vs. GG       Fixed           8.6             0.363        0.861   0.742-1.001   0.051
              AA vs. GG       Fixed           1.4             0.414        0.835   0.663-1.051   0.124
              AA+AG vs. GG    Fixed           0.0             0.541        0.838   0.728-0.965   0.014
              AA vs. AG+GG    Fixed           6.8             0.376        0.89    0.716-1.106   0.249
  Asian                                                                                          
              A vs. G         Random          96.2            \<0.001      1.435   0.762-2.699   0.263
              AG vs. GG       Fixed           23.3            0.251        0.95    0.814-1.108   0.512
              AA vs. GG       Random          67.8            0.005        0.982   0.591-1.631   0.944
              AA+AG vs. GG    Random          62.9            0.013        0.927   0.719-1.195   0.559
              AA vs. AG+GG    Fixed           50.8            0.058        0.906   0.711-1.154   0.423

XRCC1 rs25489 Polymorphism {#sec2-8}
--------------------------

As shown in [Table 6](#T6){ref-type="table"}, no significant association was detected between the XRCC1 rs25489 (Arg280His) polymorphism and TC risk under all five genetic models (A vs. G: OR = 1.044, 95 % CI =.848-1.183, P = 0.507; AG vs. GG: OR = 0.984, 95 % CI = 0.948-1.141, P = 0.836; AA vs. GG: OR = 1.154, 95 % CI = 0.803-1.658, P = 0.439, AA + AG vs. GG: OR = 1.023, 95 % CI = 0.887-1.179, P = 0.758 and AA vs. AG+GG: OR = 1.206, 95 % CI = 0.846-1.719, P = 0.300). Furthermore, when stratified by ethnicity, there were no associations between XRCC1 rs25489 polymorphism and TC risk under all five genetic models in both Asians and Caucasians.

###### 

Meta-Analysis of the Association of XRCC1 rs25489 Polymorphism with TC.

              Genetic model   Type of model   Heterogeneity   Odds ratio                         
  ----------- --------------- --------------- --------------- ------------ ------- ------------- -------
  Overall                                                                                        
              A vs. G         Fixed           23.4            0.22         1.044   0.920-1.183   0.507
              AG vs. GG       Fixed           42.4            0.067        0.984   0.848-1.141   0.836
              AA vs. GG       Fixed           0.0             0.891        1.154   0.803-1.658   0.439
              AA+AG vs. GG    Fixed           32.8            0.137        1.023   0.887-1.179   0.758
              AA vs. AG+GG    Fixed           0.0             0.894        1.206   0.846-1.719   0.3
  Ethnicity                                                                                      
  Caucasian                                                                                      
              A vs. G         Fixed           15.1            0.317        1.205   0.955-1.520   0.116
              AG vs. GG       Fixed           29.5            0.214        1.172   0.916-1.500   0.206
              AA vs. GG       Fixed           19.9            0.264        1.939   0.468-8.026   0.361
              AA+AG vs. GG    Fixed           24.9            0.248        1.194   0.936-1.521   0.153
              AA vs. AG+GG    Fixed           24.8            0.249        1.855   0.448-7.673   0.394
  Asian                                                                                          
              A vs. G         Fixed           21.5            0.278        0.983   0.847-1.142   0.825
              AG vs. GG       Fixed           44.5            0.125        0.89    0.738-1.073   0.222
              AA vs. GG       Fixed           0.0             0.974        1.113   0.765-1.619   0.575
              AA+AG vs. GG    Fixed           31.6            0.211        0.943   0.790-1.124   0.511
              AA vs. AG+GG    Fixed           0.0             0.968        1.172   0.813-1.690   0.395

Test of heterogeneity {#sec2-9}
---------------------

For XRCC1 rs1799782 (Arg194Trp) polymorphism, when we have pooled the data a significant heterogeneity observed in heterozygote (I^2^=64.0%, P~H~=0.007), homozygote (I^2^=51.90%, P~H~=0.042) and dominant (I^2^=77.9%, P~H~=0.007) genetic models ([Table 4](#T4){ref-type="table"}). After subjects stratified by ethnicity, the heterogeneity obviously disappeared in the Caucasians (heterozygote: I2=19.13%, P~H~=0.290; homozygote: I^2^=0.0%, P~H~=0.389 and dominant: I^2^=21.3%, P~H~=0.281). However, heterogeneity was still present among the Asians (heterozygote: I^2^=75.8%, P~H~=0.002; homozygote: I^2^=66.1%, P~H~=0.019and dominant: I^2^=85.2%, P~H~=\<0.001). Therefore, the observed heterogeneity between the included studies might be due to the ethnicities.

Sensitivity Analysis {#sec2-10}
--------------------

We have performed sensitivity analysis by omitting 1 study at a time, but the estimate of overall effect did not change noticeably. In addition, when we excluded the studies not in agreement with HWE, the statistical significance of the results not changed.

Publication Bias {#sec2-11}
----------------

We have used Begg's funnel plot and Egger's test to assess the publication bias. However, as show in [Figure 2A](#F2){ref-type="fig"}, [2B](#F2){ref-type="fig"}, the funnel plots did not reveal any obvious asymmetry in all genotypes in overall population, and the results of Begg's test revealed no publication bias (P\>0.05).

![Begg's Funnel Plots of XRCC1 Gene Polymorphisms and TC Risk for Publication Bias Test. Each Point Represents a Separate Study for the Indicated Association. A: XRCC1 rs1799782 polymorphism (Allele model: T vs. C) and B: XRCC1 rs25487 polymorphism (Dominant model: AA+AG vs. GG)](APJCP-18-263-g002){#F2}

Discussion {#sec1-4}
==========

The XRCC1 plays an important role in the base excision repair (BER) pathway and interacts with DNA polymerase Beta (POLB), Poly ADP ribose Polymerase (PARP) and DNA ligase III (Zhang et al., 2006). The XRCC1gene (Gene ID 37414; OMIM 21171001 and 21174504), is 33 kb long and located at chromosome 19q13.3, consists of 17 exons, and encodes a 2.2 kb transcript, which produces an enzyme called X-ray cross-complementing group 1 that is involved in base excision repair pathway (Wang et al., 2015). XRCC1 polymorphisms disrupt the interaction of XRCC1 with other enzymatic proteins and consequently overwhelm DNA repair capacity, which leads to genetic instability and carcinogenesis (Forat Yazdi et al., 2014).

In the present meta-analysis, we have evaluated the association between three most common XRCC1 gene polymorphisms including rs1799782 (Arg194Trp), rs25487 (Arg399Gln) and rs25489 (Arg280His) polymorphisms and risk of TC. To the best of our knowledge, this is the most comprehensive meta-analysis of the relationship between XRCC1 polymorphisms and the risk of TC. We have found the absence of rs25487 (Arg399Gln) and rs25489 (Arg280His) polymorphisms are significantly associated with an increased risk of TC, while the rs1799782 (Arg194Trp) polymorphism significantly associated with development of TC in the overall analysis. However, there was a significant association between XRCC1 rs25487 polymorphism risk of TC among Caucasians under allele genetic comparison (A vs. G: OR= 0.882, 95% CI = 0.794-0.979, p= 0.136) and dominant genetic comparison (AA+AG vs. GG: OR=0.838, 95% CI = 0.728-0.965, p= 0.014). Moreover, the T allele of XRCC1 rs1799782 and A allele of XRCC1 rs25487 may be as a marker for increased susceptibility to TC. Similarly, in a meta-analysis Qian et al. have not an association between XRCC1 rs25487 (Arg399Gln) and rs25489 (Arg280His) polymorphisms and TC risk in the overall analysis. However, they have not found such association for third polymorphism with risk of TC, too (Qian et al., 2012). The contribution of rs1799782 (Arg194Trp) polymorphism in development of TC was identified by Zhao et al. in meta-analysis of five studies, comprising 911 patients and 1476 controls, recently. However, inconsistent with our results, Li et al., (2014) and Wu et al., (2014) in the two different meta-analysis of 8 and 10 studies not found a significant association between TC risk and the three polymorphisms of XRCC1 gene in all genetic Models. Due to the difference in genetic backgrounds and the environment in which the subjects were lived, we have performed a subgroup analysis by ethnicity, however we found a significant association between rs1799782 and rs25487 polymorphism and TC risk in Asians and Caucasians, respectively.

Interestingly, in meta-analysis Yan et al., (2015) based on previous studies quoted that the XRCC1 rs25489 polymorphism is related to different cancers in Asian populations, including gastric cancer, bladder cancer, lung cancer, and colorectal cancer. While, this meta-analysis results and three previous meta-analysis by Qian et al., (2012) Li et al., (2014) and Wu et al., (2014) there was not such association between XRCC1 rs25489 polymorphism and risk of TC. Therefore, it seems the A allele of XRCC1 rs25489 may not be as a marker for increased susceptibility to TC.

To the best of our knowledge, the current meta-analysis made a more convincing and detailed evaluation than the previous meta-analysis did. However, there are some limitations should be also recognized in this meta-analysis. First, the included studies were restricted to just English literature, which might bias the results. Second, severe TC is a multifactorial condition that results from complex interactions between genes and environmental factors such as age, gender, ethnicity, family history, radiation exposure and iodine intake. Therefore, we might fail to receive the true associations when we only considered those three XRCC1 gene polymorphisms, but neglect the role of other genetic, polymorphisms, and environmental factors in TC. Finally, the sample size of subgroup analysis by ethnicity was limited, which may causes to reduce the power of analyses. Therefore, further studies with large sample sizes are required to gain more precise results.

In summary, the results of the meta-analysis suggest an increased risk role of the XRCC1 rs1799782 and rs25487 polymorphisms in TC development. However, there was no association between the XRCC1 rs25489 polymorphisms and TC risk. More studies with a larger sample size is needed to further evaluate the association XRCC1 gene polymorphisms and TC risk.
